Some children with severely elevated Lp(a) can be identified during universal screening for familial hypercholesterolaemia (FH) but others will be missed if clinicians rely solely on Lp(a) testing in those with hypercholesterolaemia, reported Dr Matej Mlinarič, Ljubljana University Medical Centre, Slovenia.
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
